Many patients with this life-threatening bacterial infection present with nonspecific symptoms that prompt a broad medical workup to rule out other potential sources of infection.
Researchers suggest that measures aimed at improving mood could reduce inflammation and potentially provide an alternative treatment or one that works alongside inflammatory bowel disease medications.
Addressing this autoimmune disorder characterized by thrombosis or pregnancy morbidity coupled with persistent antiphospholipid antibodies involves identifying and mitigating thrombosis risk factors.